(Q30845405)

27 June 2017

1 reference

Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review (English)

1 reference

magnetic resonance imaging

27 June 2017

1 reference

0 references

1 reference

Coenraad Dirk Adriaan Stehouwer

series ordinal

3

object named as

Coen D A Stehouwer

1 reference

27 June 2017

4

Geert Jan Biessels

1 reference

27 June 2017

author name string

Stefan L C Geijselaers

series ordinal

1

1 reference

27 June 2017

Simone J S Sep

series ordinal

2

1 reference

27 June 2017

publication date

24 August 2014

1 reference

The Lancet: Diabetes & Endocrinology

27 June 2017

published in

1 reference

27 June 2017

volume

3

1 reference

27 June 2017

issue

1

1 reference

27 June 2017

page(s)

75-89

1 reference

Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions.

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Brain imaging in patients with diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

1 reference

7 January 2021

Enhanced glucose control for preventing and treating diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Diabetes and atherosclerosis: is there a role for hyperglycemia?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Risk of dementia in diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Insulin, cognition, and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Brain imaging in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Continuous glucose monitoring and cognitive performance in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes--the ADDITION-Netherlands study: a cluster-randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive function and fine motor speed in older women with diabetes mellitus: results from the women's health initiative study of cognitive aging

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Improved diabetes control in the elderly delays global cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Risk factors for dementia in patients over 65 with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Preoperative depression is a risk factor for postoperative short-term and long-term cognitive dysfunction in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Assessment of cognitive status in patients with type 2 diabetes through the Mini-Mental Status Examination: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Neuropsychological status of elderly patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Rate of peripheral glucose change during cognitive testing predicts performance in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility--Reykjavik study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Interactive effect of central obesity and hypertension on cognitive function in older out-patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Race moderates age-related cognitive decline in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: data from the Caerphilly study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive function in Japanese elderly with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Diabetes mellitus and cognitive performance in older women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Total homocysteine and cognitive deterioration in people with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Type-2 diabetes and cognitive function in a non-demented population.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive function and glycosylated hemoglobin in older patients with type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Memory dysfunction and autonomic neuropathy in non-insulin-dependent (type 2) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Type II diabetes and cognitive function. A population-based study of Native Americans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Low BDNF is associated with cognitive deficits in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Risk factors for dementia with type 2 diabetes mellitus among elderly people in China.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Glucose levels and risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cognitive dysfunction is associated with poor diabetes control in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Hyperinsulinemia and risk of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Long-term metformin usage and cognitive function among older adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Cerebral cortical thickness in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Gray matter prefrontal changes in type 2 diabetes detected using MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Impact of blood pressure vs. glycemic factors on target organ damage in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Blood pressure and dementia - a comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Contributions of fasting and postprandial glucose to hemoglobin A1c.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Diabetes drugs and neurological disorders: new views and therapeutic possibilities.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

A summary of the ADVANCE Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese Elderly Diabetes Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970148-2

7 January 2021

10.1016/S2213-8587(14)70148-2

Identifiers

DOI

1 reference

27 June 2017

1 reference